BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vos EL, Salo-Mullen EE, Tang LH, Schattner M, Yoon SS, Gerdes H, Markowitz AJ, Mandelker D, Janjigian Y, Offitt K, Coit DG, Stadler ZK, Strong VE. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies. JAMA Surg 2020;155:1050-7. [PMID: 32997132 DOI: 10.1001/jamasurg.2020.3356] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 GASTROINTESTINAL CANCER SYNDROMES. Counseling About Cancer 2023. [DOI: 10.1002/9781119466499.ch2] [Reference Citation Analysis]
2 Gamble LA, Grant RRC, Samaranayake SG, Fasaye GA, Koh C, Korman L, Asif B, Heller T, Hernandez JM, Blakely AM, Davis JL. Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy. J Med Genet 2023;60:241-6. [PMID: 35817563 DOI: 10.1136/jmg-2022-108733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang H, Wang D, Shen Y, Sun C, Hu Q, Jiang L, Du Q. GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin. Cancer Gene Ther 2023;30:450-61. [PMID: 36460802 DOI: 10.1038/s41417-022-00566-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Decourtye-Espiard L, Guilford P. Hereditary Diffuse Gastric Cancer. Gastroenterology 2023:S0016-5085(23)00110-5. [PMID: 36740198 DOI: 10.1053/j.gastro.2023.01.038] [Reference Citation Analysis]
5 van Dieren JM, Bisseling TM, Kodach LL, van der Post CRS. Endoscopic Surveillance and Pathology of Biopsies in CDH1, CTNNA1, and HDGC-Like Families. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_13] [Reference Citation Analysis]
6 Bencivenga M, De Manzoni G, Roviello F. Prophylactic Total Gastrectomy: Techniques. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_15] [Reference Citation Analysis]
7 Stillman MD, Kusche N, Toledano S, Hilfrank KJ, Yoon C, Gabre JT, Rustgi SD, Hur C, Kastrinos F, Ryeom SW, Yoon SS. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene. J Surg Oncol 2022;126:1413-22. [PMID: 36063148 DOI: 10.1002/jso.27084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Coit DG, Strong VE. Fifty years of progress in gastric cancer. J Surg Oncol 2022;126:865-71. [PMID: 36087088 DOI: 10.1002/jso.27060] [Reference Citation Analysis]
9 Dardenne A, Sirmai L, Metras J, Enea D, Svrcek M, Benusiglio PR. Prédispositions génétiques au cancer gastrique et leur association au type histologique. Bulletin du Cancer 2022. [DOI: 10.1016/j.bulcan.2022.06.010] [Reference Citation Analysis]
10 Corso G, Magnoni F, Nicastro V, Bagnardi V, Trovato CM, Veronesi P. Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations. Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Menko FH, Monkhorst K, Hogervorst FB, Rosenberg EH, Adank M, Ruijs MW, Bleiker EM, Sonke GS, Russell NS, Oldenburg HS, van der Kolk LE. Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103642] [Reference Citation Analysis]
12 Vos EL, Nakauchi M, Capanu M, Park BJ, Coit DG, Molena D, Yoon SS, Jones DR, Strong VE. Phase II Trial Evaluating Esophageal Anastomotic Reinforcement with a Biologic, Degradable, Extracellular Matrix after Total Gastrectomy and Esophagectomy. Journal of the American College of Surgeons 2022;234:910-7. [DOI: 10.1097/xcs.0000000000000113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gamble LA, Davis JL. Surveillance and Surgical Considerations in Hereditary Diffuse Gastric Cancer. Gastrointest Endosc Clin N Am 2022;32:163-75. [PMID: 34798984 DOI: 10.1016/j.giec.2021.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Katoh H, Ishikawa S. Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations. J Hum Genet 2021;66:887-99. [PMID: 34267306 DOI: 10.1038/s10038-021-00960-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Förster A, Brand F, Banan R, Hüneburg R, Weber CAM, Ewert W, Kronenberg J, Previti C, Elyan N, Beyer U, Martens H, Hong B, Bräsen JH, Erbersdobler A, Krauss JK, Stangel M, Samii A, Wolf S, Preller M, Aretz S, Wiese B, Hartmann C, Weber RG. Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin. Acta Neuropathol 2021;142:191-210. [PMID: 33929593 DOI: 10.1007/s00401-021-02307-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Pocurull A, Herrera-Pariente C, Carballal S, Llach J, Sánchez A, Carot L, Botargues JM, Cuatrecasas M, Ocaña T, Balaguer F, Bujanda L, Moreira L. Clinical, Molecular and Genetic Characteristics of Early Onset Gastric Cancer: Analysis of a Large Multicenter Study. Cancers (Basel) 2021;13:3132. [PMID: 34201547 DOI: 10.3390/cancers13133132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Ithurralde-Argerich J, Rosner L, Rizzolo M, Faerberg A, Puma R, Ferro D, Duque C, Kujaruk M, Cuenca-Abente F. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers. J Laparoendosc Adv Surg Tech A 2021;31:729-37. [PMID: 34097461 DOI: 10.1089/lap.2021.0239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Benesch MGK, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation. Cancers (Basel) 2021;13:2622. [PMID: 34073553 DOI: 10.3390/cancers13112622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
19 Gullo I, Oliveira C, van der Post RS, van Dieren JM, Davis JL, Bougen-zhukov N, Guilford P, Carneiro F. Updated perspective and directions on hereditary diffuse gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00011-3] [Reference Citation Analysis]